Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

20.06
Delayed Data
As of 10:54am ET
 -1.81 / -8.25%
Today’s Change
7.84
Today|||52-Week Range
37.69
+13.17%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close21.87
Today’s open21.57
Day’s range20.06 - 21.57
Volume329
Average volume (3 months)17,466
Market cap$137.6M
Dividend yield--
Data as of 10:54am ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+30.30%
Earnings growth (this year)+63.04%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...-0.11-2.91%
CRMECardiome Pharma Corp-0.02-0.38%
SMMTSummit Therapeutics ...0.000.00%
--China Health Group I...-0.00-1.44%
Data as of 11:03am ET, 05/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$1.22
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Ron Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts